Evidence map›Paper›PMID 25463282›Full record

ReviewFree radical biology & medicine2015

Alternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagement.

Kenneth Hensley, Travis T Denton

Open access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Homocysteinylation and Sulfhydration in Diseases.Current neuropharmacology · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. International journal of molecular sciences · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Redox-based therapeutics in neurodegenerative disease.British journal of pharmacology · 2017
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kenneth HensleyDepartment of Pathology and Department of Neurosciences, University of Toledo Health Science Campus, 3000 Arlington Avenue, Toledo, OH 43614, USA. Electronic address: Kenneth.Hensley@utoledo.edu.
Travis T DentonDepartment of Pharmaceutical Sciences, Washington State University College of Pharmacy, P.O. Box 1495, Spokane, WA 99201, USA. Electronic address: Travis.Denton@WSU.edu.
University of Toledo · USWashington State University Spokane · US

Funding

Novel mechanisms for distal transport in developing and mature neuronsR01NS082283 · NINDS · SANFORD RESEARCH/USD · PI WEIMER, JILL M · 2014 to 2018
$1.9M
NINDS NIH HHS NS082283NINDS NIH HHS R01 NS082283
6 · The paper itself

Abstract

Scientific appreciation for the subtlety of brain sulfur chemistry has lagged, despite understanding that the brain must maintain high glutathione (GSH) to protect against oxidative stress in tissue that has both a high rate of oxidative respiration and a high content of oxidation-prone polyunsaturated fatty acids. In fact, the brain was long thought to lack a complete transsulfuration pathway (TSP) for cysteine synthesis. It is now clear that not only does the brain possess a functional TSP, but brain TSP enzymes catalyze a rich array of alternative reactions that generate novel species including the gasotransmitter hydrogen sulfide (H2S) and the atypical amino acid lanthionine (Lan). Moreover, TSP intermediates can be converted to unusual cyclic ketimines via transamination. Cell-penetrating derivatives of one such compound, lanthionine ketimine (LK), have potent antioxidant, neuroprotective, neurotrophic, and antineuroinflammatory actions and mitigate diverse neurodegenerative conditions in preclinical rodent models. This review will explore the source and function of alternative TSP products, and lanthionine-derived metabolites in particular. The known biological origins of lanthionine and its ketimine metabolite will be described in detail and placed in context with recent discoveries of a GSH- and LK-binding brain protein called LanCL1 that is proving essential for neuronal antioxidant defense; and a related LanCL2 homolog now implicated in immune sensing and cell fate determinations. The review will explore possible endogenous functions of lanthionine metabolites and will discuss the therapeutic potential of lanthionine ketimine derivatives for mitigating diverse neurological conditions including Alzheimer׳s disease, stroke, motor neuron disease, and glioma.

Indexed as

AlanineAnimalsBrainBrain DiseasesCystathionine beta-SynthaseHumansNeuroprotective AgentsOxidation-ReductionOxidative StressSulfidesSulfurAlanineCystathionine beta-SynthaselanthionineNeuroprotective AgentsSulfidesSulfurAutophagyCRMP2Free radicalGlutathioneHydrogen sulfideLanCL1LanCL2LanthionineNeuroinflammationTranssulfuration

Identifiers

PMID25463282
PMCPMC4280296
OpenAlexW2058551045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.